Form 8-K - Current report:
SEC Accession No. 0001493152-24-038700
Filing Date
2024-09-30
Accepted
2024-09-30 08:30:28
Documents
14
Period of Report
2024-09-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43535
2 ex3-1.htm EX-3.1 11666
  Complete submission text file 0001493152-24-038700.txt   236188

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sonn-20240925.xsd EX-101.SCH 3018
4 XBRL LABEL FILE sonn-20240925_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sonn-20240925_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3867
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 241336769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)